Bioventus (BVS) Cash from Investing Activities (2020 - 2026)
Bioventus' (BVS) quarterly Cash from Investing Activities came in at -$574000.0 in Q1 2026, up 30.51% YoY from -$439818.2 in Q1 2025, and up 1.03% on a QoQ basis from -$580000.0 in Q4 2025.
Bioventus (BVS) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Cash from Investing Activities data on file, last reported at -$574000.0 in Q1 2026.
- Quarterly Cash from Investing Activities rose 30.51% year-over-year to -$574000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.0 million (down 112.95% YoY) and the FY2025 annual result came in at -$3.2 million, down 114.14% from the prior year.
- Cash from Investing Activities advanced to -$574000.0 in Q1 2026, from -$580000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $45.0 million in Q3 2023 to a low of -$56.3 million in Q4 2022.
- A 5-year average of -$4.1 million and a median of -$826000.0 in 2025 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities plunged 1864.69% — and 2024, when it soared 4178.51%.
- Tracing BVS's Cash from Investing Activities over 5 years: stood at -$3.4 million in 2022, then soared by 82.63% to -$591000.0 in 2023, then soared by 4178.51% to $24.1 million in 2024, then sank by 102.41% to -$580000.0 in 2025, then gained by 1.03% to -$574000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$574000.0 (Q1 2026), -$580000.0 (Q4 2025), and -$473000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | -2.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -2.46 Mn |
| Jun 27, 2026 | -2.46 Mn |
| Mar 28, 2026 | -574,000.00 |
| Mar 28, 2026 | -574,000.00 |
| Dec 31, 2025 | -580,000.00 |
| Dec 31, 2025 | -580,000.00 |
| Sep 27, 2025 | -473,000.00 |
| Sep 27, 2025 | -473,000.00 |
| Jun 28, 2025 | -1.37 Mn |
| Jun 28, 2025 | -1.37 Mn |
| Mar 29, 2025 | -826,000.00 |
| Mar 29, 2025 | -826,000.00 |
| Dec 31, 2024 | 24.10 Mn |
| Dec 31, 2024 | 24.10 Mn |
| Sep 28, 2024 | -64,000.00 |
| Sep 28, 2024 | -64,000.00 |
| Jun 29, 2024 | -77,000.00 |
| Jun 29, 2024 | -77,000.00 |
| Mar 30, 2024 | -1.00 Mn |
| Mar 30, 2024 | -1.00 Mn |